Evotec Slashes Staff as Turnaround Plan Gathers Pace

Why It Matters

The restructuring aims to restore profitability in a weakening CRO market and positions Evotec for sustainable growth toward 2030, signaling broader consolidation pressures in drug‑discovery services.

Key Takeaways

• Horizon cuts 800 jobs, €75 M cost target.
• Total workforce now ~4,200 after 1,400 layoffs.
• Four sites closed, leaving ten global locations.
• JEB revenue up 40%, offsetting discovery decline.
• Share price hit 52‑week low post‑announcement.

Pulse Analysis

The contract‑research organization (CRO) sector has faced a prolonged slowdown, with tighter pharma budgets and heightened competition eroding margins. Evotec, once a fast‑growing European CRO, saw its valuation tumble after a $2.1 billion Halozyme takeover bid fell through and revenue slipped in 2025. The company’s prior restructuring in 2024 failed to halt the share‑price decline, prompting a more aggressive overhaul to address cost inefficiencies and market headwinds.

Horizon, Evotec’s latest overhaul, targets €75 million in annual savings through a 800‑person layoff and the shutdown of four facilities in Munich, Abingdon, Framingham and another site. By consolidating operations into ten “centres of excellence,” the firm hopes to eliminate overlap, accelerate decision‑making and boost agility for clients. Simultaneously, Evotec is channeling resources into its Just‑Evotec Biologics (JEB) platform, which delivered a 40% revenue jump to €259 million, partially offsetting a 16% decline in its traditional discovery and pre‑clinical segments.

For investors and industry observers, Evotec’s pivot underscores a broader trend of consolidation among CROs seeking scale and specialization. The aggressive cost‑cutting and focus on high‑margin biologics may improve profitability and restore confidence, but the immediate share‑price shock reflects lingering uncertainty. If Horizon delivers the projected savings and JEB growth sustains, Evotec could emerge as a leaner, more competitive player poised for steady expansion through 2030, potentially prompting rivals to reevaluate their own operating models.